friday, 18 may, 2018.. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..
. .
copyright 2018 npr. to see more, visit /www.npr.org/...
plemmons and co-authors disclosed no relevant relationships with industry..